首頁 > 市場調查報告書 > 食物/飲料

機能性食品

歐洲維生素 K2 市場預測至 2030 年 - 區域分析 - 按產品、劑型、來源和應用

市場調查報告書

商品編碼

1482004

歐洲維生素 K2 市場預測至 2030 年 - 區域分析 - 按產品、劑型、來源和應用

Europe Vitamin K2 Market Forecast to 2030 - Regional Analysis - by Product, Dosage Forms, Source, and Application

出版日期: 2024年03月04日 | 出版商:

The Insight Partners | 英文 88 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

歐洲維生素K2市場預計將從2022年的5,327萬美元成長到2030年的4.231億美元。

成人和新生兒骨質疏鬆症骨變形病例的增加推動了歐洲維生素 K2 市場

骨質疏鬆症是影響成人和嬰兒的一個日益常見的健康問題，這種疾病的特徵是骨骼衰弱和脆弱。根據國際骨質疏鬆基金會2022年的數據，全球骨質疏鬆症每年導致超過890萬例骨折，每3秒就有1例骨質疏鬆性骨折。醫療專業人士對骨質疏鬆症相關骨變形病例的激增感到擔憂。根據 Research Gate 最近的研究，維生素 K2 的潛在優勢包括支持骨骼健康並可能減少骨質疏鬆症的後果。

維生素 K2 是一種鮮為人知的維生素 K，對於維持健康的鈣代謝和骨密度至關重要。它刺激蛋白質將鈣從血液轉移到骨骼中，以確保足夠的礦化和強度。該營養素透過改善鈣吸收來幫助避免與骨質疏鬆症相關的骨折和畸形。成人骨質疏鬆症病例通常是由荷爾蒙變化、與年齡相關的骨質流失或食物攝取不足引起的。維生素 K2 補充劑在提高成人骨礦物質密度和降低骨折風險方面已顯示出良好的效果。此外，女性由於骨質疏鬆症發生率較高，成為骨保健品的主要目標族群。骨質疏鬆症相關問題的發生率不斷增加仍然是功能性食品和補充劑（例如鈣和維生素 D）的焦點，它們是支持骨骼健康的主要成分。鈣是骨骼的主要礦物質成分，而維生素則有助於鈣的吸收。然而，隨著消費者越來越意識到維生素 K2 的好處，其在食品和補充劑中的供應正在增加。此外，有人提出，維生素 K2 有助於降低破骨細胞的活性（破骨細胞會導致骨骼退化），進一步保護骨骼完整性。

新生兒可能會罹患骨質疏鬆症，尤其是早產兒。由於骨骼不成熟且脆弱，他們更容易骨折。在這些嬰兒的治療方案中，維生素 K2 可改善骨骼生長並減少骨骼異常的可能性。補充維生素 K2 可加速他們的骨骼發育，維生素 K2 支持生命早期階段的自然發生過程。因此，成人和新生兒骨質疏鬆相關骨骼異常發生率的不斷增加迫切需要有效的預防措施和治療方法。因此，補充維生素 K2 是一種潛在的補充療法，有助於鈣代謝、骨礦化和預防骨折。所有這些因素都在推動市場成長。

歐洲維生素 K2 市場概況

歐洲維生素 K2 市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。市場的成長歸因於心血管疾病盛行率的增加以及成人和新生兒骨質疏鬆症骨變形病例的增加。然而，人們對維生素 K2 益處的認知有限，阻礙了市場的成長。德國和義大利等國家預計將成為該地區市場成長的最重要貢獻者，法國、英國和西班牙等國家可能有維生素 K2 的成長機會。由於人們對美學外觀意識的增強，非手術緊膚和非手術減脂等非侵入性美容治療的激增，歐洲維生素 K2 市場預計將成長。此外，醫療器材產業的發展和美容診所數量的增加可能會提供重要的成長機會。

歐洲維生素 K2 市場收入及 2030 年預測（百萬美元）

歐洲維生素 K2 市場區隔

歐洲維生素 K2 市場按產品、劑型、來源、應用和國家細分。

根據產品，歐洲維生素 K2 市場分為 MK-4、MK-7 和組合藥物。 2022 年，MK-7 細分市場將佔據歐洲維生素 K2 市場的最大佔有率。

根據劑型，歐洲維生素 K2 市場分為膠囊和片劑、粉末和油。到 2022 年，粉末細分市場將佔據歐洲維生素 K2 市場的最大佔有率。

根據來源，歐洲維生素 K2 市場分為天然維生素 K2 和合成維生素 K2。 2022 年，天然維生素 K2 在歐洲維生素 K2 市場中佔有更大佔有率。

根據應用，歐洲維生素 K2 市場分為藥品、營養保健品和食品等。 2022 年，藥品領域佔據歐洲維生素 K2 市場的最大佔有率。

根據國家/地區，歐洲維生素 K2 市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲維生素 K2 市場佔據主導地位。

Anderson Global Group LLC、Balchem Corp、BASF SE、Glanbia Plc、International Flavors & Fragrances Inc、Koninklijke DSM NV、Lesaffre et Cie SA、Lonza Group AG 和 Novozymes AS 是歐洲維生素 K2 市場上的一些領先公司。

Osteoporosis is an increasingly common health issue affecting adults and babies, a disorder marked by weakening and fragile bones. According to International Osteoporosis Foundation 2022, globally osteoporosis causes more than 8.9 million fractures every year resulting in osteoporotic fracture in every 3 seconds. Medical professionals are concerned about the surge in osteoporosis-related bone distortion cases. As per recent studies from Research Gate, the potential advantages of vitamin K2 include supporting bone health and possibly reducing the consequences of osteoporosis.

Vitamin K2 is a lesser-known vitamin K essential for maintaining healthy calcium metabolism and bone density. It stimulates proteins that transfer calcium from the bloodstream into the bones to ensure adequate mineralization and strength. The nutrient aid in avoiding osteoporosis-related bone fractures and deformities by improving calcium absorption. Adult osteoporosis cases frequently result from hormonal changes, age-related bone loss, or inadequate food intake. Vitamin K2 supplementation has demonstrated promising outcomes in enhancing bone mineral density and lowering fracture risk among adults. In addition, women are the main target for bone health products due to their higher incidence of osteoporosis. The increasing incidence of osteoporosis-related difficulties continues to be a key focus for functional foods and supplements such as calcium and vitamin D are the primary components supporting bone health. Calcium is the main mineral component of bones, while vitamin helps with calcium absorption. changes However, as consumers are becoming more aware of the benefits of vitamin K2, its availability in foods and supplements is rising. In addition, it has been proposed that vitamin K2 aids in reducing the activity of osteoclast cells, which are responsible for bone deterioration, further protecting bone integrity.

Newborns can develop osteoporosis, especially preterm babies. They are more prone to fractures since their bones are immature and weak. Vitamin K2 improves bone growth and lessens the likelihood of bone abnormalities in the therapy regimens for these infants. Their skeletal development is accelerated by vitamin K2 supplementation, which supports the naturally occurring processes during the early stages of life. Thus, the growing number of adult and neonatal incidences of osteoporosis-related bone abnormalities creates the urgent need for efficient preventative measures and treatment approaches. Hence, vitamin K2 supplementation acts as a potential supplementary therapy that helps with calcium metabolism, bone mineralization, and the prevention of fractures. All these factors are driving the market growth.

Europe Vitamin K2 Market Overview

The Europe vitamin K2 market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The growth of the market is attributed to the increasing prevalence of CVD and growing cases of osteoporosis bone deformation in adults and newborns. However, the limited awareness regarding benefits of vitamin K2 hinders the market growth. Countries such as Germany and Italy are expected to be the most significant contributors to market growth in the region and countries such as France, the UK, and Spain are likely to have growth opportunities for vitamin K2. The European vitamin K2 market is expected to grow owing to the surge in non-invasive aesthetic treatments such as non-surgical skin tightening and non-surgical fat reductions due to increased awareness of aesthetic appearance. Furthermore, the medical devices industry developments and the rising numbers of aesthetic clinics may offer vital growth opportunities.

Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)

Europe Vitamin K2 Market Segmentation

The Europe vitamin K2 market is segmented into product, dosage forms, source, application, and country.

Based on product, the Europe vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held the largest share of the Europe vitamin K2 market in 2022.

Based on dosage forms, the Europe vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held the largest share of the Europe vitamin K2 market in 2022.

Based on source, the Europe vitamin K2 market is segmented into natural and synthetic. The natural segment held a larger share of the Europe vitamin K2 market in 2022.

Based on application, the Europe vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held the largest share of the Europe vitamin K2 market in 2022.

Based on country, the Europe vitamin K2 market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe vitamin K2 market in 2022.

Anderson Global Group LLC, Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, and Novozymes AS are some of the leading companies operating in the Europe vitamin K2 market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Vitamin K2 Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Increasing Prevalence of CVD
- 4.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns
4.2 Market Restraints
- 4.2.1 Limited Awareness Regarding Benefits of Vitamin K2
4.3 Market Opportunities
- 4.3.1 Expansion of Distribution Channel
4.4 Future Trends
- 4.4.1 Regulatory Consideration and Standards
4.5 Impact Analysis:

5. Vitamin K2 Market - Europe Market Analysis

5.1 Europe Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030

6. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Product.

6.1 Overview
6.2 Europe Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
6.3 MK-4
- 6.3.1 Overview
- 6.3.2 MK-4: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
6.4 MK-7
- 6.4.1 Overview
- 6.4.2 MK-7: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Combination Drugs
- 6.5.1 Overview
- 6.5.2 Combination Drugs: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Dosage Form.

7.1 Overview
7.2 Europe Vitamin K2 Market Revenue Share, by Dosage Form, 2022 & 2030 (%)
7.3 Capsules and Tablets
- 7.3.1 Overview
- 7.3.2 Capsules and Tablets: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Powder
- 7.4.1 Overview
- 7.4.2 Powder: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Oil
- 7.5.1 Overview
- 7.5.2 Oil: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Source.

8.1 Overview
8.2 Europe Vitamin K2 Market Revenue Share, by Source, 2022 & 2030 (%)
8.3 Natural
- 8.3.1 Overview
- 8.3.2 Natural: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Synthetic
- 8.4.1 Overview
- 8.4.2 Synthetic: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Vitamin K2 Market - Revenue and Forecast to 2030 - by Application.

9.1 Overview
9.2 Europe Vitamin K2 Market Revenue Share, by Application, 2022 & 2030 (%)
9.3 Pharmaceuticals
- 9.3.1 Overview
- 9.3.2 Pharmaceuticals: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Nutraceuticals and Food
- 9.4.1 Overview
- 9.4.2 Nutraceuticals and Food: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Vitamin K2 Market - Country Analysis

10.1.1 Europe Vitamin K2 Market by Country
- 10.1.1.1 Germany
  - 10.1.1.1.1 Overview
  - 10.1.1.1.2 Germany: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.1.3 Germany: Europe Vitamin K2 Market, by Product
  - 10.1.1.1.4 Germany: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.1.5 Germany: Europe Vitamin K2 Market, by Source
  - 10.1.1.1.6 Germany: Europe Vitamin K2 Market, by Application
- 10.1.1.2 UK
  - 10.1.1.2.1 Overview
  - 10.1.1.2.2 UK: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.2.3 UK: Europe Vitamin K2 Market, by Product
  - 10.1.1.2.4 UK: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.2.5 UK: Europe Vitamin K2 Market, by Source
  - 10.1.1.2.6 UK: Europe Vitamin K2 Market, by Application
- 10.1.1.3 France
  - 10.1.1.3.1 Overview
  - 10.1.1.3.2 France: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.3.3 France: Europe Vitamin K2 Market, by Product
  - 10.1.1.3.4 France: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.3.5 France: Europe Vitamin K2 Market, by Source
  - 10.1.1.3.6 France: Europe Vitamin K2 Market, by Application
- 10.1.1.4 Italy
  - 10.1.1.4.1 Overview
  - 10.1.1.4.2 Italy: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.4.3 Italy: Europe Vitamin K2 Market, by Product
  - 10.1.1.4.4 Italy: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.4.5 Italy: Europe Vitamin K2 Market, by Source
  - 10.1.1.4.6 Italy: Europe Vitamin K2 Market, by Application
- 10.1.1.5 Spain
  - 10.1.1.5.1 Overview
  - 10.1.1.5.2 Spain: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.5.3 Spain: Europe Vitamin K2 Market, by Product
  - 10.1.1.5.4 Spain: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.5.5 Spain: Europe Vitamin K2 Market, by Source
  - 10.1.1.5.6 Spain: Europe Vitamin K2 Market, by Application
- 10.1.1.6 Rest of Europe
  - 10.1.1.6.1 Overview
  - 10.1.1.6.2 Rest of Europe: Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  - 10.1.1.6.3 Rest of Europe: Europe Vitamin K2 Market, by Product
  - 10.1.1.6.4 Rest of Europe: Europe Vitamin K2 Market, by Dosage Form
  - 10.1.1.6.5 Rest of Europe: Europe Vitamin K2 Market, by Source
  - 10.1.1.6.6 Rest of Europe: Europe Vitamin K2 Market, by Application

11. Vitamin K2 Market Industry Landscape

11.1 Overview
11.2 Growth Strategies in Vitamin K2 Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Lonza Group AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 International Flavors & Fragrances Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Balchem Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 BASF SE
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Lesaffre et Cie SA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Koninklijke DSM NV
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Novozymes AS
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Glanbia Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Anderson Global Group LLC
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Europe Vitamin K2 Market Segmentation
Table 2. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 3. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 4. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
Table 5. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 6. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 7. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 8. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
Table 9. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 10. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 11. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 12. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - End-User
Table 13. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 14. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 15. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 16. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
Table 17. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 18. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 19. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 20. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
Table 21. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 22. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
Table 23. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
Table 24. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
Table 25. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
Table 26. Recent Organic Growth Strategies in Vitamin K2 Market
Table 27. Recent Inorganic Growth Strategies in the Vitamin K2 Market
Table 28. Glossary of Terms, Europe Vitamin K2 Market

List Of Figures

Figure 1. Europe Vitamin K2 Market Segmentation, By Country
Figure 2. Europe Vitamin K2 Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Europe Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. MK-4: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. MK-7: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Combination Drugs: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
Figure 10. Capsules and Tablets: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Powder: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Oil: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
Figure 14. Natural: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Synthetic: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
Figure 17. Pharmaceuticals: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Nutraceuticals and Food: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Vitamin K2 Market, By Country, 2022 ($Mn)
Figure 21. Europe Vitamin K2 Market, By Key Countries, 2022 And 2030 (%)
Figure 22. AS is the most common valvular heart disease, with a dismal prognosis when untreated. Recommended therapy is SAVR or TAVR.
Figure 23. Germany: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 24. UK: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 25. France: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 26. Italy: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 27. Spain: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 28. Rest of Europe: Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
Figure 29. Growth Strategies in Vitamin K2 Market